Ypsomed's autoinjector YpsoMate

Promising start-up opts for Ypsomed's user-friendly autoinjector to treat PMDD

News – Ypsomed Delivery Systems - EN

Asarina Pharma has decided to go with our user-friendly two-step autoinjector YpsoMate for its commercial launch of its drug Sepranolone. Sepranolone is the world’s first treatment for pre-menstrual dysphoric disorder (PMDD).

Market entry of YpsoMate autoinjector for Teribone™ in Japan
Teribone™ autoinjector

News – Ypsomed Delivery Systems - EN

Burgdorf – Terumo Corporation (Terumo), a leading global manufacturer and distributor of medical devices, will fill its PLAJEX™ syringe with the drug Teribone™ and assemble it with the YpsoMate prefilled autoinjector from Ypsomed. Teribone™ is a Teriparatide for the treatment of osteoporosis. The drug was developed by Asahi Kasei Pharma (AKP) and will be launched in Japan.

YpsoDose patch injector in use

Satisfied user study participants

News – Ypsomed Delivery Systems - EN

YpsoDose is a patch injector for large volumes. When developing YpsoDose, we focus on user-friendliness as we do with all our injection systems. The latest user studies have confirmed how easy YpsoDose is to use. 

Ypsomed's autoinjector YspoMate

YpsoMate's platform approach is paying off

News – Ypsomed Delivery Systems - EN

Several customers have recently launched their autoinjectors based on our YpsoMate platform product technology on the market. Customers value the fast product customisation as well as the individual design possibilities. End users appreciate its user-friendliness.

News – Ypsomed Delivery Systems - EN

Ypsomed Delivery Systems is presenting its range of self-injection device platforms at CPhI in Frankfurt, 5-7 November 2019.

News – Ypsomed Delivery Systems - EN

Ypsomed is excited to participate at the PDA The Universe of Prefilled Syringes and Injection Devices in Gothenburg, Sweden, 22 - 23 October 2019.

News – Ypsomed Delivery Systems - EN

Ian Thompson, Business Development, and Christoph Berger, Innovation Officer, will be attending PODD: Partnerships in Drug Delivery in Boston on 7-8 October. We look forward to discussing the latest drug delivery trends with you, in addition to Ypsomed’s patch injector and connected platform products and services.

News – Ypsomed Delivery Systems - EN

Ypsomed is showcasing its complete range of self-injection devices at the upcoming CPhI China in Shanghai June 18-20, 2019.

News – Ypsomed Delivery Systems - EN

Ypsomed is looking forward to exhibiting at BIO International Convention 2019 in Philadelphia from June 3-6.

Copaxone PEN from Teva

News – Ypsomed Delivery Systems - EN

Burgdorf – Teva Pharmaceutical Industries Ltd. (Teva), a global leader in generic medicines with innovative treatments in select areas, including CNS, pain and respiratory, has launched its drug product Copaxone® in the pre-filled autoinjector YpsoMate® from Ypsomed. Copaxone® is used for the treatment of patients with relapsing forms of multiple sclerosis (MS). The collaboration with Teva marks the
second commercial market entry of Ypsomed’s autoinjector YpsoMate®.